Cover Image

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance.This study is a randomized, open-label, controlled clinical trial aimed to eval...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paulo R Machado (Author), Julia Ampuero (Author), Luiz H Guimarães (Author), Leonardo Villasboas (Author), Ana T Rocha (Author), Albert Schriefer (Author), Rosana S Sousa (Author), Anette Talhari (Author), Gerson Penna (Author), Edgar M Carvalho (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2010-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.
by: Luiz Henrique Guimarães, et al.
Published: (2016)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
by: Jacilara Conceição, et al.
Published: (2016)

Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
by: Jamile Lago, et al.
Published: (2019)

Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil.
by: Juliana Silva, et al.
Published: (2017)

Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
by: Diego M Santos, et al.
Published: (2014)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
by: Rachel L. Sadowsky, BA, et al.
Published: (2022)

Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
by: Bhushan Madke, et al.
Published: (2011)

Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.
by: Stephen M Christensen, et al.
Published: (2016)

Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
by: Jorge Augusto de Oliveira Guerra, et al.
Published: (2011)

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
by: Adriano C Coelho, et al.
Published: (2014)

Detecção de DNA de Leishmania braziliensis em pacientes de leishmaniose tegumentar americana Detección de DNA de Leishmania braziliensis en pacientes de leishmaniose tegumentaria americana Detection of Leishmania braziliensis DNA in American tegumentary leishmaniasis patients
by: Leila Martins, et al.
Published: (2010)

Correction: Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.
by: Stephen M Christensen, et al.
Published: (2017)

Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana
by: Charlene Oliveira, et al.
Published: (2024)

Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis.
by: Marcia W Carneiro, et al.
Published: (2016)

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.
by: Thomas P C Dorlo, et al.
Published: (2011)

Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in Multiple Cutaneous Lesions.
by: Paulo R Cortes, et al.
Published: (2016)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up.
by: Adriano C Coelho, et al.
Published: (2016)

Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium.
by: Juliana A Silva, et al.
Published: (2022)

A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
by: Adriano C Coelho, et al.
Published: (2016)

Factores de riesgo para la transmisión de leishmaniasis cutánea en niños de 0 a 5 años en un área endémica de Leishmania (Viannia) braziliensis
by: Julia Ampuero, et al.

Factores de riesgo para la transmisión de leishmaniasis cutánea en niños de 0 a 5 años en un área endémica de Leishmania (Viannia) braziliensis
by: Julia Ampuero, et al.

Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
by: Saskia van Henten, et al.
Published: (2021)

Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
by: Laura Fernanda Neira, et al.
Published: (2023)

Therapeutic Efficacy of <i>Arnica</i> in Hamsters with Cutaneous Leishmaniasis Caused by <i>Leishmania braziliensis</i> and <i>L. tropica</i>
by: Sara M. Robledo, et al.
Published: (2022)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
by: Vasundhra Bhandari, et al.
Published: (2012)

Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
by: Ayelet Ollech, et al.
Published: (2020)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
by: Suzette Kämink, et al.
Published: (2021)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis
by: Daniel Holanda Barroso, et al.
Published: (2021)

IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection.
by: Daniel Schnorr, et al.
Published: (2012)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.
by: Kimbra G Turner, et al.
Published: (2015)

Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil.
by: Felipe Jules de Araujo, et al.
Published: (2015)

Combining diagnostic procedures for the management of leishmaniasis in areas with high prevalence of Leishmania guyanensis Procedimentos diagnósticos combinados no manejo da leishmaniose em áreas com alta prevalência de Leishmania guyanensis
by: Ednelza de Almeida Benicio, et al.
Published: (2011)

Multilocus sequence analysis for Leishmania braziliensis outbreak investigation.
by: Mariel A Marlow, et al.
Published: (2014)

Exposure to Leishmania braziliensis triggers neutrophil activation and apoptosis.
by: Sarah A C Falcão, et al.
Published: (2015)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
by: Masoumeh Tayyebi, et al.
Published: (2021)

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
by: Brandon A Berger, et al.
Published: (2017)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition.
by: Dimitri Bulté, et al.
Published: (2021)

Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.
by: Eliza V C Alves-Ferreira, et al.
Published: (2015)

Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.
by: Tatiana R de Moura, et al.
Published: (2007)

Toxicity and Anti-promastigote Activity of Benzoxazinoid Analogs Against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum
by: Gilberto de Sousa, et al.
Published: (2020)